Mayo Clinic Proceedings Home

Epithelioid Sarcoma: A Clinicopathologic Review of 55 Cases


      To identify any clinical and pathologic features or treatment modalities that are predictive of outcome in patients with epithelioid sarcoma, a rare slow-growing soft tissue tumor most commonly occurring in the distal extremities of young adults.


      We reviewed the institutional files for cases of epithelioid sarcoma for the period 1956 to 1991 and analyzed the effect of various factors on survival.

      Material and Methods

      Fifty-five cases of epithelioid sarcoma were found, and the relevant clinical, pathologic, treatment, follow-up, and outcome features were assessed.


      All tumors were treated initially by operative resection. The recurrence rate progressively decreased with increasing aggressiveness of the initial operation; however, no difference was noted in metastatic rate. Overall, the recurrence rate was 38% and the metastatic rate was 47%. At the end of a mean follow-up of 102 months, 69% of patients had no evidence of disease, 27% had died of the disease, and 4 % were alive with disease. Increasing tumor size, necrosis of more than 30%, and vascular invasion correlated significantly with a worse prognosis.


      Epithelioid sarcoma should be considered a malignant neoplasm with a significant potential for aggressive behavior, and close follow-up of affected patients should be maintained for many years. Initial treatment should be aggressive in an attempt to prevent recurrence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chase DR
        • Enzinger FM
        Epithelioid sarcoma: diagnosis, prognostic indicators, and treatment.
        Am J Surg Pathol. 1985; 9: 241-263
        • Enzinger FM
        Epithelioid sarcoma: a sarcoma simulating a granuloma or a carcinoma.
        Cancer. 1970; 26: 1029-1041
        • Wevers AC
        • Kroon BBR
        • Albus-Lutter EC
        • Gortzak E
        Epithelioid sarcoma.
        Eur J Surg Oncol. 1989; 15: 345-349
        • Bos GD
        • Pritchard DJ
        • Reiman HM
        • Dobyns JH
        • Ilstrup DM
        • Landon GC
        Epithelioid sarcoma: an analysis of fifty-one cases.
        J Bone Joint Surg Am. 1988; 70: 862-870
        • Giorno R
        A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction.
        Diagn Immunol. 1984; 2: 161-166
        • Hedley DW
        • Friedlander ML
        • Taylor IW
        • Rugg CA
        • Musgrove EA
        Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.
        J Histochem Cytochem. 1983; 31: 1333-1335
        • El-Naggar AK
        • Garcia GM
        Epithelioid sarcoma: flow cytometric study of DNA content and regional DNA heterogeneity.
        Cancer. 1992; 69: 1721-1728
        • Pastel-Levy C
        • Bell DA
        • Rosenberg AE
        • Preffer F
        • Colvin RB
        • Flotte TJ
        DNA flow cytometry of epithelioid sarcoma.
        Cancer. 1992; 70: 2823-2826
        • Shimm DS
        • Suit HD
        Radiation therapy of epithelioid sarcoma.
        Cancer. 1983; 52: 1022-1025
        • Steinberg BD
        • Gelberman RH
        • Mankin HJ
        • Rosenberg AE
        Epithelioid sarcoma in the upper extremity.
        J Bone Joint Surg Am. 1992; 74: 28-35